FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 307:644-652 September 9, 1982 Number 11 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To formulate indications for the use of hepatitis B vaccine, we examined the cost effectiveness of three strategies: vaccinating everyone; screening everyone and vaccinating those without evidence of immunity; and neither vaccinating nor screening, but passively immunizing those with known exposure. Estimates of the hepatitis attack rate, prevalence of immunity, and frequency of known exposure were made for three representative populations: homosexual men, surgical residents, and the general population of the United States. Screening followed by vaccination of homosexual men and vaccination without prior screening of surgical residents would result in savings of medical costs. Neither screening nor vaccination is the lowest-cost strategy for the general population. Vaccination of susceptible persons will save medical costs for populations with annual attack rates above 5 per cent. Vaccination may be considered cost effective (or cost saving when indirect costs are included) for populations with attack rates as low as 1 to 2 per cent.

This article has been cited by other articles:

• Djeriri, K., Laurichesse, H., Merle, J. L., Charof, R., Abouyoub, A., Fontana, L., Benchemsi, N., Elharti, E., El Aouad, R., Chamoux, A., Beytout, J. (2008). Hepatitis B in Moroccan health care workers. Occup Med (Lond) 58: 419-424 [Abstract] [Full Text]  
• Zhou, F., Santoli, J., Messonnier, M. L., Yusuf, H. R., Shefer, A., Chu, S. Y., Rodewald, L., Harpaz, R. (2005). Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001. Arch Pediatr Adolesc Med 159: 1136-1144 [Abstract] [Full Text]  
• Levaux, H. P., Schonfeld, W. H., Pellissier, J. M., Cassidy, W. M., Sheriff, S. K., Fitzsimon, C. (2001). Economic Evaluation of a 2-Dose Hepatitis B Vaccination Regimen for Adolescents. Pediatrics 108: 317-325 [Abstract] [Full Text]  
• Feudtner, C., Marcuse, E. K. (2001). Ethics and Immunization Policy: Promoting Dialogue to Sustain Consensus. Pediatrics 107: 1158-1164 [Abstract] [Full Text]  
• Fendrick, A. M., Lee, J. H., LaBarge, C., Glick, H. A. (1999). Clinical and Economic Impact of a Combination Haemophilus influenzae and Hepatitis B Vaccine: Estimating Cost-effectiveness Using Decision Analysis. Arch Pediatr Adolesc Med 153: 126-136 [Abstract] [Full Text]  
• Wiebe, T., Fergusson, P., Horne, D., Shanahan, M., Macdonald, A., Heise, L., Roos, L. L. (1997). Hepatitis B Immunization in a Low-incidence Province of Canada: Comparing Alternative Strategies. Med Decis Making 17: 472-482 [Abstract]  
• Margolis, H. S., Coleman, P. J., Brown, R. E., Mast, E. E., Sheingold, S. H., Arevalo, J. A. (1995). Prevention of Hepatitis B Virus Transmission by Immunization: An Economic Analysis of Current Recommendations. JAMA 274: 1201-1208 [Abstract]  
• Wong, E. S., Stotka, J. L., Chinchilli, V. M., Williams, D. S., Stuart, C. G., Markowitz, S. M. (1991). Are Universal Precautions Effective in Reducing the Number of Occupational Exposures Among Health Care Workers? A Prospective Study of Physicians on a Medical Service. JAMA 265: 1123-1128 [Abstract]  
• Halliday, M. L., Rankin, J. G., Bristow, N. J., Coates, R. A., Corey, P. N. J., Strickler, A. C. (1990). A Randomized Double-blind Clinical Trial of a Mammalian Cell-Derived Recombinant DNA Hepatitis B Vaccine Compared With a Plasma-Derived Vaccine. Arch Intern Med 150: 1195-1200 [Abstract]  
• Dawson, N. V., Cebul, R. D. (1990). Advances in Quantitative Techniques for Making Medical Decisions: The Last Decade. Eval Health Prof 13: 37-62 [Abstract]  
• Clarke, J. A., Hollinger, F. B., Lewis, E., Russell, L. A., Miller, C. H., Huntley, A., Flynn, N. M. (1989). Intradermal Inoculation With Heptavax-B: Immune Response and Histologic Evaluation of Injection Sites. JAMA 262: 2567-2571 [Abstract]  
• Hicks, R. A., Cullen, J. W., Jackson, M. A., Burry, V. F. (1989). Hepatitis B Virus Vaccine: Cost-Benefit Analysis of its Use in a Children's Hospital. CLIN PEDIATR 28: 359-365 [Abstract]  
• Reese, C. E., Ockner, R. K. (1989). Prevention of Hepatitis B in Surgeons and Their Patients. PERSPECT VASC SURG ENDOVASC THER 2: 138-147  
• WILLIAMS, W. W., HICKSON, M. A., KANE, M. A., KENDAL, A. P., SPIKA, J. S., HINMAN, A. R. (1988). Immunization Policies and Vaccine Coverage Among Adults: The Risk for Missed Opportunities. ANN INTERN MED 108: 616-625 [Abstract]  
• Arevalo, J. A., Washington, A. E. (1988). Cost-effectiveness of Prenatal Screening and Immunization for Hepatitis B Virus. JAMA 259: 365-369 [Abstract]  
• KASSIRER, J. P., MOSKOWITZ, A. J., LAU, J., PAUKER, S. G. (1987). Decision Analysis: A Progress Report. ANN INTERN MED 106: 275-291 [Abstract]  
• Brewster, J. M. (1986). Prevalence of Alcohol and Other Drug Problems Among Physicians. JAMA 255: 1913-1920 [Abstract]  
• Detsky, A. S., Mclaughlin, J. R., Abrams, H. B., Whittaker, J. S., Whitwell, J., L'Abbe, K., Jeejeebhoy, K. N. (1986). A Cost-Utility Analysis of the Home Parenteral Nutrition Program at Toronto General Hospital: 1970-1982. JPEN J Parenter Enteral Nutr 10: 49-57 [Abstract]  
• Redfield, R. R., Innis, B. L., Scott, R. M., Cannon, H. G., Bancroft, W. H. (1985). Clinical Evaluation of Low-Dose Intradermally Administered Hepatitis B Virus Vaccine: A Cost Reduction Strategy. JAMA 254: 3203-3206 [Abstract]  
• Osterholm, M. T., Garayalde, S. M. (1985). Clinical Viral Hepatitis B Among Minnesota Hospital Personnel: Results of a Ten-Year Statewide Survey. JAMA 254: 3207-3212 [Abstract]  
• Remafedi, G. J. (1985). Adolescent Homosexuality: Issues for Pediatricians. CLIN PEDIATR 24: 481-485 [Abstract]  
• KESSLER, H. A., HARRIS, A. A., PAYNE, J. A., HUDSON, E., POTKIN, B., LEVIN, S. (1985). Antibodies to Hepatitis B Surface Antigen as the Sole Hepatitis B Marker in Hospital Personnel. ANN INTERN MED 103: 21-26 [Abstract]  
• Twomey, P. L., Patching, S. C. (1985). Cost-Effectiveness of Nutritional Support. JPEN J Parenter Enteral Nutr 9: 3-10  
• HEALTH AND PUBLIC POLICY COMMITTEE, (1984). Hepatitis B Vaccine. ANN INTERN MED 100: 149-150 [Abstract]  
• Hamilton, J. D. (1983). Hepatitis B Virus Vaccine: An Analysis of Its Potential Use in Medical Workers. JAMA 250: 2145-2150 [Abstract]  
• Francis, D. P. (1983). Hepatitis B Virus Vaccine An Opportunity for Control. JAMA 250: 1891-1892 [Abstract]  
• SCHWARTZ, A. M., CHORBA, T. L. (1983). Hepatitis Vaccine and the Acquired Immunodeficiency Syndrome. ANN INTERN MED 99: 567-568 [Abstract]